PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of bmjcrInstructions for authorsCurrent ToCBMJ Case Reports
 
BMJ Case Rep. 2010; 2010: bcr1220092591.
Published online 2010 August 31. doi:  10.1136/bcr.12.2009.2591
PMCID: PMC3027574
Rare disease
SAPHO syndrome with bacillus Calmette-Guérin (BCG) immunotherapy for bladder cancer
Katsuhiko Matsumaru,1 Kazuki Nagai,1 Takayuki Murakami,2 and Kazuo Andoh3
1Department of Internal Medicine, Nagai Clinic, Yokohama, Japan
2Department of Urology, Yokohama Minamikyousai Hospital, Yokohama, Japan
3Department of Radiology, Saiseikai Yokohama-Shi Nanbu Hospital, Yokohama, Japan
Correspondence to Katsuhiko Matsumaru, matsuckkid/at/yahoo.co.jp
Abstract
The authors describe a case of SAPHO syndrome with bacillus Calmette-Guérin (BCG) immunotherapy for bladder cancer. The patient had undergone transurethral resection (TUR) and was treated with BCG immunotherapy following TUR. Two years after treatment for bladder cancer, the patient had palmoplantar pustulosis, and in the past 1 month suffered from pain localised to the anterior chest wall. The bone scintigraphy showed a strong focal enrichment in the right chest wall, suggesting spondyloarthropathy rather than malignant disease. On the basis of clinical and scintigraphy findings, SAPHO syndrome was diagnosed. The patient was treated with topical therapy and non-steroidal anti-inflammatory drugs and symptoms improved. The authors suggest that SAPHO syndrome might be caused by an association with BCG immunotherapy.
Articles from BMJ Case Reports are provided here courtesy of
BMJ Group